Impact of haemoglobin variants on the use of haemoglobin A1c for the diagnosis and monitoring of diabetes: a contextualised review
- PMID: 35362846
- PMCID: PMC9892076
- DOI: 10.1007/s11845-022-02967-2
Impact of haemoglobin variants on the use of haemoglobin A1c for the diagnosis and monitoring of diabetes: a contextualised review
Abstract
HbA1c is the established test for monitoring glycaemic control in diabetes, and intervention trials studying the impact of treatment on glycaemic control and risk of complications focus predominantly on this parameter in terms of evaluating the glycaemic outcomes. It is also the main parameter used when targets for control are being individualised, and more recently, it has been used for the diagnosis of type 2 diabetes. For laboratories performing this test and clinicians utilising it in their decision-making process, a thorough understanding of factors that can impact on the accuracy, and appropriate interpretation of the test is essential. The changing demographic in the Irish population over the last two decades has brought this issue sharply into focus. It is therefore timely to review the utility, performance and interpretation of the HbA1c test to highlight factors impacting on the results, specifically the impact of haemoglobin variants, and the impact of these factors on its utilisation in clinical practice.
Keywords: Diabetes; Diagnosis; Haemoglobinopathy; HbA1c.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
References
-
- Nathan DM, Genuth S, Lachin J et al (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329 (14):977–986. 10.1056/nejm199309303291401 - PubMed
-
- United Kingdom Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 352 (9131):837–853. 10.1016/S0140-6736(98)07019-6 - PubMed
-
- Census (2016) summary results - part 1, https://www.cso.ie/en/media/csoie/newsevents/documents/census2016summary..., downloaded Jan 2022
-
- Agyemang C, van den Born BJ (2019) Non-communicable diseases in migrants: an expert review. J Travel Med 26(2). 10.1093/jtm/tay107 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
